%1

OEHHA has selected chemicals for the Developmental and Reproductive Toxicant Identification Committee's review for possible listing under Proposition 65 as causing reproductive toxicity (developmental toxicity endpoint).

The listing of bevacizumab is based on a formal requirement by the US Food and Drug Administration that the chemical be identified or labeled as causing reproductive toxicity.

This request is limited to exposures to crystalline silica (airborne particles of respirable size) from the four specified WOODWISE® wood filler products.

This request is limited to exposures to bisphenol A from the specified eyewear products (prescription glasses, OTC reading glasses, non-prescription sunglasses, and safety glasses).

NOTICE IS HEREBY GIVEN that the Office of Environmental Health Hazard Assessment (OEHHA) proposes to adopt new sections to Article 6 of Title 27 of the California Code of Regulations.[1]  Subsequent to the adoption of the new Article 6 of Title 27, California Code of Regs on August 30, 2016 and the amendments to the regulations on November 20, 2017 to clarify and make more specific certain provisions of Article 6, OEHHA received a request to adopt tailored safe harbor exposure warnings for exposures to listed chemicals from rental v

The regulation will be effective on April 1, 2019.  This regulation establishes a No Significant Risk Level of 0.95 micrograms per day for bromodichloroacetic acid for purposes of Proposition 65.

The regulation will be effective on April 1, 2019.  This regulation establishes a No Significant Risk Level of 0.70 micrograms per day for bromochloroacetic acid for purposes of Proposition 65.